DNMT3A moderates cognitive decline in subjects with mild cognitive impairment: replicated evidence from two mild cognitive impairment cohorts

Leonidas Chouliaras, Gunter Kenis, Pieter Jelle Visser, Philip Scheltens, Magda Tsolaki, Roy W. Jones, Patrick G. Kehoe, Caroline Graff, Nicola G. Girtler, Asa K. Wallin, Marcel Olde Rikkert, Luiza Spiru, Lyzel S. Elias-Sonnenschein, Inez H. G. B. Ramakers, Ehsan Pishva, Jim van Os, Harry W. M. Steinbusch, Frans R. J. Verhey, Daniel L. A. van den Hove, Bart P. F. Rutten

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
Original languageEnglish
Pages (from-to)533-537
JournalEpigenomics
Volume7
Issue number4
DOIs
Publication statusPublished - 2015

Keywords

  • aging
  • DNA methylation
  • DNMT3A
  • epigenetics
  • MCI
  • mild cognitive impairment
  • SNP

Cite this

Chouliaras, L., Kenis, G., Visser, P. J., Scheltens, P., Tsolaki, M., Jones, R. W., Kehoe, P. G., Graff, C., Girtler, N. G., Wallin, A. K., Rikkert, M. O., Spiru, L., Elias-Sonnenschein, L. S., Ramakers, I. H. G. B., Pishva, E., van Os, J., Steinbusch, H. W. M., Verhey, F. R. J., van den Hove, D. L. A., & Rutten, B. P. F. (2015). DNMT3A moderates cognitive decline in subjects with mild cognitive impairment: replicated evidence from two mild cognitive impairment cohorts. Epigenomics, 7(4), 533-537. https://doi.org/10.2217/EPI.15.22